• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)

    9/30/25 10:20:00 AM ET
    $CVS
    $VRT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Industrial Machinery/Components
    Technology
    Get the next $CVS alert in real time by email

    TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE:VRT) as worthy of further study and has named the company its "Stock to Study" for the December 2025 issue for investors' informational and educational use.

    The fundamental data is eye-opening; investors can view Vertiv's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/study/ssgplus/?studyid=17125916.

    A full report on Vertiv will appear in the December 2025 issue of BetterInvesting Magazine. 

    The same issue of BetterInvesting Magazine will also include a fundamental review of CVS Health Corp. (NYSE:CVS), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

    Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

    Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

    Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn, Instagram and Facebook.

    Contact: 877-275-6242

    Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-vertiv-holdings-co-nyse-vrt-and-cvs-health-corp-nyse-cvs-302571020.html

    SOURCE National Association of Investors/BetterInvesting

    Get the next $CVS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $VRT

    CompanyDatePrice TargetRatingAnalyst
    CVS Health Corporation
    $CVS
    10/14/2025$91.00Buy
    Goldman
    Vertiv Holdings LLC
    $VRT
    8/20/2025$135.00Neutral
    Rothschild & Co Redburn
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    CVS Health Corporation
    $CVS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    Vertiv Holdings LLC
    $VRT
    7/28/2025Outperform
    William Blair
    Vertiv Holdings LLC
    $VRT
    7/8/2025$165.00Hold → Buy
    Melius
    Vertiv Holdings LLC
    $VRT
    4/8/2025$75.00Buy
    ROTH MKM
    Vertiv Holdings LLC
    $VRT
    3/7/2025$121.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $CVS
    $VRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    2/19/25 12:35:35 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vertiv to Participate in Upcoming Investor Conference

    COLUMBUS, Ohio, Oct. 17, 2025 /PRNewswire/ -- Vertiv Holdings Co (NYSE:VRT), a global leader in critical digital infrastructure, today announced its participation in an upcoming investor conference in November. Giordano Albertazzi, Chief Executive Officer, will participate in a fireside chat at the Baird 2025 Global Industrial Conference in Chicago, Illinois on Tuesday, November 11, 2025 at 2:20 p.m. Central time (3:20 p.m. Eastern time). A live webcast of the event and any related presentation materials will be available in the Investor Relations section of Vertiv's website a

    10/17/25 8:00:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Pharmacy completes acquisition of Rite Aid assets nationwide

    Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I., Oct. 15, 2025 /PRNewswire/ -- CVS Pharmacy today announced the completion of its acquisition of select Rite Aid assets nationwide. In total, the company acquired and is now operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. CVS Pharmacy also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. As a result of the transactions, CVS Pharmacy is pleased to be serving more than nine million former Rite Aid and Bartell Drugs patients.

    10/15/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: New insider Capozzi Heidi B claimed ownership of 5 shares (SEC Form 3)

    3/A - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:06:56 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Chief Human Resources Officer Poncheri Frank was granted 1 shares, increasing direct ownership by 0.02% to 8,265 units (SEC Form 4)

    4 - Vertiv Holdings Co (0001674101) (Issuer)

    9/26/25 4:11:08 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Rothschild & Co Redburn initiated coverage on Vertiv with a new price target

    Rothschild & Co Redburn initiated coverage of Vertiv with a rating of Neutral and set a new price target of $135.00

    8/20/25 9:03:10 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    SEC Filings

    View All

    Vertiv Holdings LLC filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vertiv Holdings Co (0001674101) (Filer)

    10/14/25 6:03:57 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    9/22/25 4:19:42 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    9/8/25 4:59:27 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Financials

    Live finance-specific insights

    View All

    CVS Pharmacy completes acquisition of Rite Aid assets nationwide

    Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I., Oct. 15, 2025 /PRNewswire/ -- CVS Pharmacy today announced the completion of its acquisition of select Rite Aid assets nationwide. In total, the company acquired and is now operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. CVS Pharmacy also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. As a result of the transactions, CVS Pharmacy is pleased to be serving more than nine million former Rite Aid and Bartell Drugs patients.

    10/15/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Announces Date of Third Quarter 2025 Earnings Release and Conference Call

    COLUMBUS, Ohio, Oct. 8, 2025 /PRNewswire/ -- Vertiv Holdings Co. (NYSE:VRT), a global leader in critical digital infrastructure, today announced it will report its third quarter 2025 results before market open on Wednesday, October 22, 2025. The press release will contain a link to the presentation materials providing a third quarter 2025 update, which will be available on Vertiv's website at investors.vertiv.com. Vertiv's management team will discuss the results during a conference call the same day, starting at 11 a.m. Eastern Time. A webcast of the live conference call can

    10/8/25 8:00:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    CVS Health to hold third quarter 2025 earnings conference call

    WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

    9/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Vertiv Holdings LLC

    SC 13G - Vertiv Holdings Co (0001674101) (Subject)

    11/13/24 4:34:55 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Vertiv Holdings LLC

    SC 13G/A - Vertiv Holdings Co (0001674101) (Subject)

    11/12/24 5:49:48 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Announces Leadership Transition in EMEA Region

    Paul Ryan named as president, Europe, Middle East and Africa as of January 1, 2026 COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ -- Vertiv (NYSE:VRT), a global leader in critical digital infrastructure, today announced that Karsten Winther will retire from his position as president, Europe, Middle East and Africa (EMEA), effective December 31, 2025. Paul Ryan, currently chief procurement officer, has been appointed as his successor, starting January 1, 2026. "Karsten has made impactful contributions to Vertiv during his tenure, particularly in strengthening our EMEA region throug

    10/13/25 10:45:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Vertiv Names Craig Chamberlin as Chief Financial Officer

    COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ -- Vertiv Holdings Co (NYSE:VRT), a global leader in critical digital infrastructure, today announced the appointment of Craig Chamberlin as Executive Vice President and Chief Financial Officer, effective November 10, 2025. Mr. Chamberlin succeeds David Fallon, who previously announced his intention to retire from Vertiv and serve as a consultant to the company through December 31, 2026. Mr. Chamberlin joins Vertiv from Wabtec Corporation, where he most recently served as Group Vice President and Chief Financial Officer of the company

    10/13/25 6:45:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology